Table 4.
Correlation of TXNIP with different nerve conduction velocities in patients with type 2 diabetes.
B | S.E. | β | Adjusted R2 | F | 95%CI | P | |
---|---|---|---|---|---|---|---|
Left ulnar MCV | −2.092 | 0.790 | −0.154 | 0.098 | 5.175 | (−3.649, −0.536) | 0.009** |
Right ulnar MCV | −1.727 | 0.757 | −0.131 | 0.122 | 6.316 | (−3.217, −0.238) | 0.023* |
Left median MCV | −1.530 | 0.633 | −0.135 | 0.174 | 9.085 | (−2.776, −0.284) | 0.016* |
Right median MCV | −1.509 | 0.635 | −0.135 | 0.142 | 7.318 | (−2.758, −0.259) | 0.018* |
Left common peroneal MCV | −1.174 | 0.649 | −0.105 | 0.113 | 5.786 | (−2.453, 0.105) | 0.072 |
Right common peroneal MCV | −1.112 | 0.637 | −0.101 | 0.123 | 6.288 | (−2.367, 0.142) | 0.082 |
Left tibial MCV | −1.148 | 0.604 | −0.108 | 0.167 | 8.540 | (−2.338,0.040) | 0.058 |
Right tibial MCV | −0.959 | 0.599 | −0.089 | 0.193 | 9.984 | (−2.139,0.221) | 0.111 |
Left ulnar SCV | −0.598 | 0.856 | −0.041 | 0.112 | 5.643 | (−2.284, 1.087) | 0.485 |
Right ulnar SCV | −0.622 | 0.864 | −0.043 | 0.080 | 4.226 | (−2.323, 1.080) | 0.472 |
Left median SCV | −1.989 | 1.011 | −0.114 | 0.137 | 6.834 | (−3.981, 0.002) | 0.050 |
Right median SCV | 0.176 | 1.104 | 0.009 | 0.154 | 7.542 | (−1.998, 2.350) | 0.873 |
Left superficial peroneal SCV | −1.629 | 0.883 | −0.116 | 0.076 | 3.827 | (−3.368, 0.111) | 0.066 |
Right superficial peroneal SCV | −0.822 | 1.006 | −0.053 | 0.027 | 1.958 | (−2.805, 1.160) | 0.415 |
Left sural SCV | −0.352 | 0.928 | −0.024 | 0.050 | 2.902 | (−2.179,1.475) | 0.705 |
Right sural SCV | −1.460 | 0.927 | −0.099 | 0.042 | 2.542 | (−3.287,0.366) | 0.116 |
P < 0.05,
P < 0.01 NCVA vs. NCVN.
MCV, motor nerve conduction velocity; SCV, sensory nerve conduction velocity.